Skip to main content
Top
Published in: Journal of General Internal Medicine 5/2009

Open Access 01-05-2009 | Original Article

Factors Associated with Osteoporosis Screening and Recommendations for Osteoporosis Screening in Older Adults

Authors: Smita Nayak, MD, Mark S. Roberts, MD, MPP, Susan L. Greenspan, MD

Published in: Journal of General Internal Medicine | Issue 5/2009

Login to get access

ABSTRACT

BACKGROUND

Osteoporosis screening rates are low, and it is unclear which patient factors are associated with screening and physician recommendations for screening.

OBJECTIVE

To identify patient characteristics associated with osteoporosis screening recommendations and receipt of screening in older adults.

DESIGN

Cross-sectional mailed survey.

PARTICIPANTS

Women and men ≥60 years old living in or near western Pennsylvania.

MEASUREMENTS

Sociodemographic characteristics and osteoporosis-related data, including risk factors, physician recommendations for screening, and receipt of screening. Multivariable logistic regression analyses were performed to determine odds ratios for receipt of screening and screening recommendations for individuals with particular osteoporosis risk factors, adjusting for sociodemographic and other risk factors.

RESULTS

Surveys were completed by 1,268 of the 1,830 adults to whom surveys were mailed (69.3%). Most respondents were white (92.9%), female (58.7%), and believed they were in good to excellent health (88.2%). Only 47.6% said their physician recommended osteoporosis screening, and 62.6% of all respondents reported being screened. Screening recommendations were less likely for older respondents than younger ones (OR, 0.87 per 5-year increase in age; 95% CI, 0.77–0.97). Individuals with osteoporosis risk factors of a history of oral steroid use for >1 month, height loss >2.54 cm, or history of low-trauma fracture were no more likely to report screening recommendations than individuals without these characteristics. Receipt of screening was no more likely for more elderly respondents or respondents with a history of oral steroid use for >1 month than for respondents without these characteristics.

CONCLUSIONS

Individuals with several known osteoporosis risk factors are not being sufficiently targeted for screening.
Appendix
Available only for authorised users
Literature
1.
go back to reference U.S. Department of Health and Human Services. Bone health and osteoporosis: a report of the surgeon general. Rockville, MD: U.S. Department of Health and Human Services, Office of the Surgeon General; 2004. U.S. Department of Health and Human Services. Bone health and osteoporosis: a report of the surgeon general. Rockville, MD: U.S. Department of Health and Human Services, Office of the Surgeon General; 2004.
2.
go back to reference Looker AC, Orwoll ES, Johnston CC Jr., et al. Prevalence of low femoral bone density in older U.S. adults from NHANES III. J Bone Miner Res. 1997; 12: 1761–8.PubMedCrossRef Looker AC, Orwoll ES, Johnston CC Jr., et al. Prevalence of low femoral bone density in older U.S. adults from NHANES III. J Bone Miner Res. 1997; 12: 1761–8.PubMedCrossRef
3.
go back to reference Burge R, Dawson-Hughes B, Solomon DH, et al. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res. 2007; 22: 465–75.PubMedCrossRef Burge R, Dawson-Hughes B, Solomon DH, et al. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res. 2007; 22: 465–75.PubMedCrossRef
4.
go back to reference Nelson HD, Helfand M, Woolf SH, Allan JD. Screening for postmenopausal osteoporosis: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002; 137: 529–41.PubMed Nelson HD, Helfand M, Woolf SH, Allan JD. Screening for postmenopausal osteoporosis: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002; 137: 529–41.PubMed
5.
go back to reference Nguyen TV, Eisman JA, Kelly PJ, Sambrook PN. Risk factors for osteoporotic fractures in elderly men. Am J Epidemiol. 1996; 144: 255–63.PubMed Nguyen TV, Eisman JA, Kelly PJ, Sambrook PN. Risk factors for osteoporotic fractures in elderly men. Am J Epidemiol. 1996; 144: 255–63.PubMed
6.
go back to reference Huddleston JM, Whitford KJ. Medical care of elderly patients with hip fractures. Mayo Clin Proc. 2001; 76: 295–8.PubMedCrossRef Huddleston JM, Whitford KJ. Medical care of elderly patients with hip fractures. Mayo Clin Proc. 2001; 76: 295–8.PubMedCrossRef
7.
go back to reference Braithwaite RS, Col NF, Wong JB. Estimating hip fracture morbidity, mortality and costs. J Am Geriatr Soc. 2003; 51: 364–70.PubMedCrossRef Braithwaite RS, Col NF, Wong JB. Estimating hip fracture morbidity, mortality and costs. J Am Geriatr Soc. 2003; 51: 364–70.PubMedCrossRef
8.
go back to reference Nevitt MC, Ettinger B, Black DM, et al. The association of radiographically detected vertebral fractures with back pain and function: a prospective study. Ann Intern Med. 1998; 128: 793–800.PubMed Nevitt MC, Ettinger B, Black DM, et al. The association of radiographically detected vertebral fractures with back pain and function: a prospective study. Ann Intern Med. 1998; 128: 793–800.PubMed
9.
go back to reference Oleksik A, Lips P, Dawson A, et al. Health-related quality of life in postmenopausal women with low BMD with or without prevalent vertebral fractures. J Bone Miner Res. 2000; 15: 1384–92.PubMedCrossRef Oleksik A, Lips P, Dawson A, et al. Health-related quality of life in postmenopausal women with low BMD with or without prevalent vertebral fractures. J Bone Miner Res. 2000; 15: 1384–92.PubMedCrossRef
10.
go back to reference Cummings SR, Nevitt MC, Browner WS, et al. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med. 1995; 332: 767–73.PubMedCrossRef Cummings SR, Nevitt MC, Browner WS, et al. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med. 1995; 332: 767–73.PubMedCrossRef
11.
go back to reference Kanis JA on behalf of the World Health Organization Scientific Group. Assessment of Osteoporosis at the Primary Health Care Level. 2008 Technical Report. University of Sheffield, UK: WHO Collaborating Center; 2008. Kanis JA on behalf of the World Health Organization Scientific Group. Assessment of Osteoporosis at the Primary Health Care Level. 2008 Technical Report. University of Sheffield, UK: WHO Collaborating Center; 2008.
12.
go back to reference Screening for osteoporosis in postmenopausal women: recommendations and rationale. Ann Intern Med. 2002;137:526–8. Screening for osteoporosis in postmenopausal women: recommendations and rationale. Ann Intern Med. 2002;137:526–8.
13.
go back to reference The National Osteoporosis Foundation (NOF). Clinician’s Guide to prevention and treatment of osteoporosis. Washington, DC: National Osteoporosis Foundation; 2008. The National Osteoporosis Foundation (NOF). Clinician’s Guide to prevention and treatment of osteoporosis. Washington, DC: National Osteoporosis Foundation; 2008.
14.
go back to reference Qaseem A, Snow V, Shekelle P, et al. Screening for osteoporosis in men: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2008; 148: 680–4.PubMed Qaseem A, Snow V, Shekelle P, et al. Screening for osteoporosis in men: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2008; 148: 680–4.PubMed
15.
go back to reference Kiebzak GM, Beinart GA, Perser K, et al. Undertreatment of osteoporosis in men with hip fracture. Arch Intern Med. 2002; 162: 2217–22.PubMedCrossRef Kiebzak GM, Beinart GA, Perser K, et al. Undertreatment of osteoporosis in men with hip fracture. Arch Intern Med. 2002; 162: 2217–22.PubMedCrossRef
16.
go back to reference Morris CA, Cabral D, Cheng H, et al. Patterns of bone mineral density testing: current guidelines, testing rates, and interventions. J Gen Intern Med. 2004; 19: 783–90.PubMedCrossRef Morris CA, Cabral D, Cheng H, et al. Patterns of bone mineral density testing: current guidelines, testing rates, and interventions. J Gen Intern Med. 2004; 19: 783–90.PubMedCrossRef
17.
go back to reference Gehlbach SH, Fournier M, Bigelow C. Recognition of osteoporosis by primary care physicians. Am J Public Health. 2002; 92: 271–3.PubMedCrossRef Gehlbach SH, Fournier M, Bigelow C. Recognition of osteoporosis by primary care physicians. Am J Public Health. 2002; 92: 271–3.PubMedCrossRef
18.
go back to reference Solomon DH, Brookhart MA, Gandhi TK, et al. Adherence with osteoporosis practice guidelines: a multilevel analysis of patient, physician, and practice setting characteristics. Am J Med. 2004; 117: 919–24.PubMedCrossRef Solomon DH, Brookhart MA, Gandhi TK, et al. Adherence with osteoporosis practice guidelines: a multilevel analysis of patient, physician, and practice setting characteristics. Am J Med. 2004; 117: 919–24.PubMedCrossRef
19.
go back to reference Curtis JR, Westfall AO, Allison JJ, et al. Longitudinal patterns in the prevention of osteoporosis in glucocorticoid-treated patients. Arthritis Rheum. 2005; 52: 2485–94.PubMedCrossRef Curtis JR, Westfall AO, Allison JJ, et al. Longitudinal patterns in the prevention of osteoporosis in glucocorticoid-treated patients. Arthritis Rheum. 2005; 52: 2485–94.PubMedCrossRef
20.
go back to reference Shah SK, Gecys GT. Prednisone-induced osteoporosis: an overlooked and undertreated adverse effect. J Am Osteopath Assoc. 2006; 106: 653–7.PubMed Shah SK, Gecys GT. Prednisone-induced osteoporosis: an overlooked and undertreated adverse effect. J Am Osteopath Assoc. 2006; 106: 653–7.PubMed
21.
go back to reference Morris CA, Cheng H, Cabral D, Solomon DH. Predictors of screening and treatment of osteoporosis: a structural review of the literature. Endocrinologist. 2004; 14: 70–5.CrossRef Morris CA, Cheng H, Cabral D, Solomon DH. Predictors of screening and treatment of osteoporosis: a structural review of the literature. Endocrinologist. 2004; 14: 70–5.CrossRef
22.
go back to reference Miller RG, Ashar BH, Cohen J, et al. Disparities in osteoporosis screening between at-risk African-American and white women. J Gen Intern Med. 2005; 20: 847–51.PubMedCrossRef Miller RG, Ashar BH, Cohen J, et al. Disparities in osteoporosis screening between at-risk African-American and white women. J Gen Intern Med. 2005; 20: 847–51.PubMedCrossRef
23.
go back to reference Solomon DH, Morris C, Cheng H, et al. Medication use patterns for osteoporosis: an assessment of guidelines, treatment rates, and quality improvement interventions. Mayo Clin Proc. 2005; 80: 194–202.PubMedCrossRef Solomon DH, Morris C, Cheng H, et al. Medication use patterns for osteoporosis: an assessment of guidelines, treatment rates, and quality improvement interventions. Mayo Clin Proc. 2005; 80: 194–202.PubMedCrossRef
24.
go back to reference Marci CD, Anderson WB, Viechnicki MB, Greenspan SL. Bone mineral densitometry substantially influences health-related behaviors of postmenopausal women. Calcif Tissue Int. 2000; 66: 113–8.PubMedCrossRef Marci CD, Anderson WB, Viechnicki MB, Greenspan SL. Bone mineral densitometry substantially influences health-related behaviors of postmenopausal women. Calcif Tissue Int. 2000; 66: 113–8.PubMedCrossRef
25.
go back to reference Fitt NS, Mitchell SL, Cranney A, et al. Influence of bone densitometry results on the treatment of osteoporosis. CMAJ. 2001; 164: 777–81.PubMed Fitt NS, Mitchell SL, Cranney A, et al. Influence of bone densitometry results on the treatment of osteoporosis. CMAJ. 2001; 164: 777–81.PubMed
26.
go back to reference Solomon DH, Katz JN, Finkelstein JS, et al. Osteoporosis improvement: a large-scale randomized controlled trial of patient and primary care physician education. J Bone Miner Res. 2007; 22: 1808–15.PubMedCrossRef Solomon DH, Katz JN, Finkelstein JS, et al. Osteoporosis improvement: a large-scale randomized controlled trial of patient and primary care physician education. J Bone Miner Res. 2007; 22: 1808–15.PubMedCrossRef
27.
go back to reference van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C. Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology(Oxford). 2000; 39: 1383–9.CrossRef van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C. Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology(Oxford). 2000; 39: 1383–9.CrossRef
Metadata
Title
Factors Associated with Osteoporosis Screening and Recommendations for Osteoporosis Screening in Older Adults
Authors
Smita Nayak, MD
Mark S. Roberts, MD, MPP
Susan L. Greenspan, MD
Publication date
01-05-2009
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 5/2009
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-009-0936-6

Other articles of this Issue 5/2009

Journal of General Internal Medicine 5/2009 Go to the issue

Reflection

Stuck

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.